Description
KADCYLA® 160 mg es un medicamento de uso intravenoso que contiene Trastuzumab Emtansina (T-DM1)
Cada tableta contiene 40 mg de afatinib
XATRAL OD 10 MG | Comprimidos de liberación prolongada | Caja con 28 TAB | Sanofi Aventis
300 ML Aerosol
Puede causar efectos sobre el sistema nervioso central
TRILEPTAL 60MG 1ML SUSP 100ML OTCLABORATORIOS SANFER SA DE C KADCYLA® 160 mg es unPRINCIPIO ACTIVO: OXCARBAMAZEPINA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
